天臣医疗（688013）8月6日主力资金净卖出1588.63万元

Core Viewpoint - Tianchen Medical (688013) experienced a decline in stock price, closing at 37.88 yuan on August 6, 2025, down 4.51% from the previous day, indicating a negative trend in investor sentiment and market performance [1]. Group 1: Stock Performance and Trading Data - On August 6, 2025, the stock had a turnover rate of 7.1%, with a trading volume of 57,600 hands and a total transaction value of 215 million yuan [1]. - The net outflow of main funds was 15.8863 million yuan, accounting for 7.41% of the total transaction value, while retail investors saw a net inflow of 5.1648 million yuan, representing 2.41% of the total [1]. - Over the past five days, the stock has shown fluctuating performance, with a notable drop on August 6, following a slight increase on August 4 [1][2]. Group 2: Financing and Margin Trading - As of August 6, 2025, the financing balance was 102 million yuan, with a net financing purchase of 12.9725 million yuan, indicating positive investor interest in leveraging positions [2]. - The margin trading data shows no short selling activity, with a total margin trading balance of 102 million yuan [2]. Group 3: Company Financials and Industry Comparison - Tianchen Medical reported a total market capitalization of 3.074 billion yuan, significantly lower than the industry average of 11.525 billion yuan, ranking 101 out of 123 in the medical device sector [4]. - The company’s net profit for the first quarter of 2025 was 13.1867 million yuan, reflecting a year-on-year increase of 16.16%, while its main revenue was 65.8461 million yuan, up 9.34% year-on-year [4]. - The company has a gross margin of 58.46%, which is higher than the industry average of 51.31%, indicating strong operational efficiency [4].